Keyphrases
Bloodstream Infection
33%
Infectious Diseases Consultation
27%
New York City
25%
Bacteremia
24%
Risk Factors
24%
Catheter-related Bloodstream Infection (CRBSI)
24%
Ventilator-associated Pneumonia
23%
Antimicrobial Use
22%
Confidence Interval
20%
Antimicrobial
19%
Meningitis
18%
Vancomycin-resistant Enterococci
18%
Healthcare Workers
18%
Ventilator-associated
17%
Hemodialysis
17%
Antimicrobial Stewardship
15%
Chlorhexidine
15%
Antibiotics
15%
Telavancin
14%
Burn Patients
14%
Asia
14%
Worse Outcome
14%
Tertiary Care Hospital
14%
Thailand
14%
Hospital-acquired
14%
Enterococcus
14%
Diagnostic Criteria
14%
External Ventricular Drain
14%
Soft Tissue Infection
14%
Skin Tissue
14%
Trauma Patients
14%
Surgical Site Infection
14%
Elderly Patients
14%
Haemophilus Influenzae Type b
14%
H. Influenzae Type b
14%
Staphylococcus Aureus
14%
Health Systems
13%
Mupirocin
12%
Infection Prevention
12%
Infection-related Ventilator-associated Complications
12%
Antimicrobial Stewardship Program
12%
Ventilator Support
12%
Disease Prevention
11%
Centers for Disease Control
11%
Healthcare Facilities
11%
Clinical Outcomes
11%
Academic Medical Centers
11%
Vancomycin
11%
Catheter
11%
Clinical Characteristics
11%
Medicine and Dentistry
Infection
100%
Bloodstream Infection
32%
Ventilator-Associated Pneumonia
23%
Catheter Infection
21%
Staphylococcus Aureus
19%
Antiinfective Agent
17%
Health Care
16%
Disease
15%
Pseudomonic Acid
14%
Tertiary Care
14%
Injury
14%
Diagnosis
14%
Thermal Burn
14%
Soft Tissue Infection
14%
External Ventricular Drain
14%
Infectious Disease
14%
Intensive Care Unit
14%
Prevalence
12%
Infection Prevention
11%
Consultation
11%
COVID-19
11%
Chlorhexidine
10%
Antifungal Agent
10%
Infection Rate
10%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Antibiotics
9%
Candidemia
9%
Prospective Study
8%
Vancomycin
8%
Randomized Controlled Trial
8%
Antibiotic Prophylaxis
8%
Klebsiella pneumoniae
8%
Enterococcus
7%
Clostridium Difficile Infection
7%
Prophylaxis
7%
Health Care Facility
7%
Hand Hygiene
7%
Healthcare Associated Infection
7%
Antivirus Agent
7%
Cancer Treatment
7%
Acute Cholecystitis
7%
Mantoux Test
7%
Thrombophlebitis
7%
Fusobacterium
7%
Respiratory Failure
7%
Esthetic Surgery
7%
Systematic Review
7%
Isoniazid
7%
Clinical Management
7%
Antifungal Medication
7%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
75%
Bloodstream Infection
28%
Antiinfective Agent
26%
Meningitis
17%
Hemodialysis
16%
Diseases
16%
Catheter Infection
15%
Haemophilus influenzae
14%
Quinolone Derivative
14%
Telavancin
14%
Vancomycin
14%
Antifungal Agent
13%
Antibiotics
12%
Disease
12%
Vancomycin-Resistant Enterococcus
10%
Escherichia coli
9%
Cohort Study
8%
Klebsiella pneumoniae
8%
SARS Coronavirus
7%
Brain Ventriculitis
7%
Enterococcal Infection
7%
Bacterial Endocarditis
7%
Taurolidine
7%
Thrombophlebitis
7%
Heparin
7%
Vancomycin Intermediate Staphylococcus Aureus
7%
Ventilator Associated Pneumonia
7%
Candidemia
7%
Respiratory Failure
7%
Prospective Study
7%
Antibiotic Prophylaxis
7%
Acute Cholecystitis
7%
Injury
7%
Malignant Neoplasm
7%
Tuberculin
7%
Isoniazid
7%
Neurocysticercosis
7%
Randomized Controlled Trial
7%
Surgical Infection
7%
Acute Kidney Failure
7%
Coronavirinae
7%
Invasive Candidiasis
7%
Systemic Mycosis
7%
Invasive Aspergillosis
7%
End Stage Renal Disease
6%
Antivirus Agent
5%